Click on a filter below to refine your search. Remove a filter to broaden your search.
Medicare spending was higher for adults with a formal clinical diagnosis of dementia versus a positive screening for cognitive impairment.
Immediate and lasting reductions were seen in the share of patients receiving hospice care with the Alzheimer’s disease and related dementia code.
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
Now the 59 million Americans covered by Medicare Part B can get up to eight free, at-home tests each month.
The percentage of older U.S. decedents with a diagnosis of Alzheimer’s disease and related dementias increased significantly from 2004 to 2017.
At-home tests will be available at pharmacies and other locations for clients with Medicare Part B outpatient benefit.
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
The court also was hearing arguments on separate vaccine mandate for most heathcare workers.
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
The increase was due to 36% increase in federal expenditures, mainly in response to the COVID-19 pandemic.